The U.S. Attempts to Mislead the World Into Thinking That India Is Its Ally Against China

All Global Research articles can be read in 51 languages by activating the Translate This Article button below the author’s name.

To receive Global Research’s Daily Newsletter (selected articles), click here.

Follow us on Instagram and Twitter and subscribe …

The post The U.S. Attempts to Mislead the World Into Thinking That India Is Its Ally Against China appeared first on Global Research.

WATCH – ‘My life is in danger:’ Orthodox blogger mobbed by ‘defenders of democracy’

Katz had invited two lawyers, one in favor of the judicial reform and one against, to debate the matter.

By World Israel News Staff

A visibly Orthodox video journalist was mobbed by a crowd of protesters in Tel Aviv with shouts of “shame, shame.”

Yehuda Katz, from TribeJournal, set out to document the protests in Tel Aviv as he had done in past weeks as part of an ongoing surveyal of the pulse of the protesters.

According to Katz, he sought to hear what their concerns are about the judicial reform and why they believe it to be a “threat to democracy.”

Katz had invited two lawyers, one in favor of the judicial reform and one against, to debate the matter on camera in front of the Azrieli towers where the protesters were encamped throughout the day.

Within moments, Katz and the lawyers, one of whom was also visibly dressed as an Orthodox Jew with a large black yarmulke, caught the eye of surrounding protesters and were immediately surrounded by hundreds of angry protesters screaming, blowing horns directly into his ears, and attempting to drive him away. One protester warned Katz that he would not be allowed to “turn Israel into a halachic state.”

“Apparently I’m the only one who wants to understand both sides,” Katz said.

“I’m beginning to understand how this works,” he added, as a cameraman and reporter from Israel’s Ynet TV approached him for a standup interview.

“The protesters make a ruckus, the media covers the ruckus, and then the protesters splash their messaging in the background as they photobomb the media’s coverage of the ruckus,” he said, as a woman behind the Ynet reporter held up a large sign reading, “Biblical disaster.”

“This isn’t democracy,” he added.

“My life is in danger,” Katz said, noting that he didn’t feel as threatened when filming face-offs between Jews and Arabs in Jerusalem’s flashpoint Sheikh Jarrah neighborhood.

Katz noted, however, that on previous excursions to the protests, he had not encountered problems when
engaging protesters in intellectual discussions.

Most protesters he had met at the weekly Saturday night protests “were peaceful, welcoming and took the time to explain their issues with the judicial reform on camera.”

“These people are clearly distraught. A few hundred loud apples don’t spoil the whole bunch. Although I did not get to hear the two lawyers debate the issues, I can not say that I did not hear just how emotional the judicial reform is for this group of extremists.” He added, “It was quite strange and shockingly ironic that any group would silence conversation in the name of defending a democracy.”

The post WATCH – ‘My life is in danger:’ Orthodox blogger mobbed by ‘defenders of democracy’ appeared first on World Israel News.

The Biden Administration Is Letting Big Pharma Profiteer Off a Cancer Drug

Under existing law, Joe Biden and his health secretary have the power to lower the price of medicines developed with taxpayer funds. They’re refusing to do so for the $180,000-a-year cancer drug Xtandi — after a furious lobbying campaign by Big Pharma.

President Joe Biden delivers remarks at the White House Conservation In Action Summit at the US Interior Department on March 21, 2023, in Washington, DC. (Kevin Dietsch / Getty Images)

In the summer of 2020, then California attorney general Xavier Becerra demanded Donald Trump’s administration use existing law to lower the price of medicines that were originally developed at taxpayer expense.

“We cannot afford to leave the supply of this critical medication to chance and the whims of the marketplace when it was funded in part by taxpayer dollars,” Becerra wrote in a letter to the Trump administration in response to the high price of Remdesivir, which treats COVID-19.

Less than three years later, the agency run by Becerra — now Health and Human Services (HHS) secretary in the Biden administration — just rejected the same demand from two cancer patients unable to afford the $180,000-a-year price of a medicine whose development was originally funded by the public.

Current law allows regulators to rescind exclusive patent protections for government-developed drugs when “action is necessary to alleviate health or safety needs” or when a medicine is not “available to the public on reasonable terms.”

However, in rejecting that move for the prostate drug Xtandi, the National Institutes of Health — which is part of HHS — declared that the purpose of existing law is designed “to promote the commercialization and public availability of government-funded inventions,” with a primary purpose “to allow government funding recipients to own patent rights.”

Becerra’s department sided with pharmaceutical companies Pfizer and Astellas, despite Astellas selling the prostate cancer medicine in other countries at a fraction of its price in the United States.

The patent holders of Xtandi  — whose ingredients were developed at a California public university — have earned more than $20 billion from the drug, according to the American Prospect.

Biden’s Record on Drug Prices

Becerra’s decision may be a dramatic about-face, but it is consistent for his boss, President Joe Biden.

Biden was vice president when the Obama administration rejected congressional Democrats’ demand that the government use the same power to lower the skyrocketing prices of medicine in America.

As a senator in 2000, Biden was one of just eight Democrats who helped pharmaceutical lobbyists kill a measure spearheaded by Sen. Paul Wellstone (D-MN) and then representative Bernie Sanders (I-VT) that would have reinstated the Reagan-era requirement that drug companies sell medicines developed with public money at a reasonable price.

That requirement was repealed by the Clinton administration in 1995, following pressure by drugmakers.

“Understandably, members of the public are concerned that the prices they pay are higher than those in other high-income countries,” the Biden administration wrote in a letter to cancer patients on Tuesday, adding that officials share “your concern about the high price of drugs and the burden it places on patients and their families, particularly the uninsured and the underinsured.”

However, the administration insisted that it was rejecting the petition to use so-called “march-in rights” to seize the patents on Xtandi because the prostate cancer drug is “widely available to the public on the market.”

The administration did not respond to our request for comment.

Americans Fund Pharma R&D, Get Rewarded With World’s Highest Prices

Studies have shown that most, if not all, major new drugs are originally developed with funding from the US government. But at the urging of pharmaceutical lobbyists — and as nearly a quarter billion dollars of pharmaceutical industry campaign cash flowed to both parties — federal officials have refused to use their existing power to reduce the US prices of those drugs.

The result: the American public is financing pharmaceutical research and development and then being rewarded for that investment with the world’s highest prices for medicine, all while drugmakers report ever-higher profit margins.

Prior to joining the Biden administration, Becerra had criticized this situation, expressing support for using executive authority to crack down on high drug prices.

As a member of Congress in 2016, Becerra signed on to a letter to Barack Obama’s Department of Health and Human Services calling on officials to broadly use “march-in rights” to lower the cost of prescription drugs — including “specialty drugs, like those to treat cancer, which are frequently developed with taxpayer funds.”

Under the Bayh-Dole Act, passed four decades ago, the federal government can waive patent exclusivity for drugs whose research was funded by federal government dollars, speeding the arrival of far-cheaper generics to the market.

In this case, the patent on Xtandi is held by pharma giant Astellas, which in turn shares the US market with Pfizer. Xtandi has proven to be effective in treating prostate cancer, and is on the World Health Organization’s List of Essential Medicines.

And yet, despite march-in rights enshrined in the Bayh-Dole Act, federal officials have never exercised those rights, even as drug prices have skyrocketed.

Big Pharma’s Big Lobbying Campaign

A furious lobbying campaign led up to Becerra’s reversal on the question of march-in rights.

The US Chamber of Commerce, which spent more than $80 million lobbying in 2022, explicitly stated in public reports that it was lobbying on a “petition to HHS to grant march-in rights for the patents on the drug Xtandi.”

The chamber’s board of directors includes a top lobbyist from Pfizer, which has disclosed lobbying the White House on “Bayh-Dole March-In Rights.” Astellas has also lobbied on “issues related to march-in rights under the Bayh-Dole Act.”

The powerful drug lobby Pharmaceutical Research and Manufacturers of America, known as PhRMA, similarly reported lobbying on “Bayh-Dole march-in rights policy issues.”

Pfizer spent $15 million on lobbying in 2022, while PhRMA spent $29 million. Astellas spent $2 million on lobbying.

Texas representative Lloyd Doggett, the top Democrat on the Ways and Means Committee’s Health Subcommittee, panned the administration’s decision in a statement Tuesday.

“Today’s decision is a blow to prostate cancer patients, their families, and taxpayers,” said Doggett, adding: “The Biden Administration has missed yet another opportunity to do something meaningful to lower prescription drug costs and protect taxpayer investments. Its decision protects monopolists over taxpayers and patients, despite clear statutory authority and reasonableness to intervene.”

You can subscribe to David Sirota’s investigative journalism project, the Lever, here.

Father Facetimes Mother While Choking Daughter to Death

A toddler’s life was lost in a senseless tragedy: the death of two-year-old Zevaya Marie Flanagan has left many hearts broken, clinging to memories while struggling with grief.

The girl’s father, Deontray Flanagan, allegedly killed her following an altercation with her mother in a Harris County Walmart Kairsten Watson, who worked there.

According to Watson, Flanagan physically attacked her, grabbing her phone and threatening to harm the child if she did not obey his demands.

After forcing her to give him her passcode, he took Zevaya and led police on an extensive half-hour chase in a desperate attempt to hide from authorities.

Reports indicate that Zevaya was injured and required CPR as a result. Watson stated that Flanagan had Facetimed her while choking his daughter, and she had begged him to stop, saying that Zevaya loved him. Although she was flown to a hospital, it was too late, and the girl succumbed to her injuries.

Shock and disbelief have been accompanied by outrage, as it was revealed that Watson had contacted authorities thrice, warning them of Flanagan’s abusive behavior toward her, but that she had received no assistance.

Now, Flanagan is charged with murder and held in jail with a $2 million bail. The tragedy has sparked a conversation on the importance of taking domestic violence seriously, providing better protection for victims, and encouraging better communication between those affected and law enforcement agencies. The death of Zevaya Marie Flanagan is a painful reminder of the potential harm that can come from inaction.

Free-Market Idolatry and Hatred of Democracy Go Hand in Hand

After reading historian Quinn Slobodian’s new book, you are not likely to think about capitalism the same way. As one blurb aptly put it, the story is “head-spinning,” and, by the way, great fun to read. Slobodian is a professor of the history of ideas at Wellesley College and bearer of one of my favorite […]

Netanyahu halts bill against Christian proselytizing while Jews in Israel are increasingly targeted

“Any attempts to curb evangelizing in the Jewish state, via legislation, is met with international pressure and cries of church persecution and violations of religious freedom.”

By Associated Press and World Israel News Staff

Israeli Prime Minister Benjamin Netanyahu on Wednesday said he would prevent the passage of a proposal by a powerful ally in his governing coalition to punish Christian proselytizing with jail time.

The proposal had raised an uproar with evangelical Christians — one of Israel’s strongest and most influential supporters in the United States.

The bill was introduced in January by a pair of ultra-Orthodox Jewish lawmakers, including Moshe Gafni, who heads the parliament’s Finance Committee. It says soliciting someone to convert their faith should be punishable by one year in prison and solicitation to convert a minor would be punishable with a two-year sentence.

“Recently, the attempts of missionary groups, mainly Christians, to solicit conversion of religion have increased,” it said.

The bill was never advanced, but it drew widespread attention in the American evangelical world this week after All Israel News, an evangelical news site, reported on it.

On Wednesday, Netanyahu announced on Twitter: “We will not advance any law against the Christian community.”

Gafni said he had introduced the bill as a procedural matter, as he has done in the past, and there were no plans to advance it.

Evangelical Christians, particularly in the United States, are among the strongest backers of Israel, viewing it as the fulfillment of biblical prophecy, with some seeing it as the harbinger of a second coming of Jesus Christ and the end of days.

Israel has long welcomed evangelicals’ political and financial support, and it has largely shrugged off concerns about any hidden religious agenda. But most Jews view any effort to convert them to Christianity as deeply offensive, a legacy of centuries of persecution and forced conversion at the hands of Christian rulers.

Aggressive missionary activity targeting Jews in Israel has become rampant in recent years.

Ellen Horowitz is the former content and research director for an Israeli organization exploring the challenges and complexities of Israel’s alliances with fundamentalist, evangelical and messianic Christian groups.

“In my many years of researching the Israel-Evangelical relationship, I find that ‘to the Jew first’ still motivates evangelical churches and their proxy messianic congregations and projects in Israel. Both covert and overt missionary activity runs rampant and largely unchecked in Israel,” Horowitz told World Israel News.

“Any attempts to curb evangelizing in the Jewish state, via legislation, is met with international pressure and cries of church persecution and violations of religious freedom,” she said.

Joel Rosenberg, editor in chief of All Israel News, welcomed Netanyahu’s announcement, which comes at a time of domestic turmoil in Israel over his plan to overhaul the country’s legal system and rising tensions with the Biden administration over settlement activities in Judea and Samaria.

“Netanyahu is a longtime and proven friend to the global Christian community and his action today — amidst all the other issues on his plate — is further proof,” Rosenberg said.

The post Netanyahu halts bill against Christian proselytizing while Jews in Israel are increasingly targeted appeared first on World Israel News.

Manhunt Over After Gruesome Discovery in Colorado Woods

Law enforcement in Denver was searching for Austin Lyle, a 17-year-old East High School student accused of shooting two administrators on Wednesday morning.

Denver police identified Lyle as a Black male measuring 5 feet 5 inches and weighing 150 pounds. He was last seen wearing a green colored hoodie.

The coroner verified Thursday morning that the accused shooter, Austin Lyle is dead. It is reported that the 17-year-old student, believed to have shot the two school administrators on Wednesday at East High School in Denver, was found dead in the woods close to an abandoned car.

Sheriff Tom McGraw of Park County revealed that the body was located on Wednesday in a far-off mountain area which is approximately 50 miles away from Denver, in the vicinity of Bailey, a small town in Park County.

The shooting was reported at 9:50 a.m. on Wednesday; it happened while Lyle was undergoing daily search procedures. Authorities had launched a manhunt for Lyle after the shooting and were offering a $2,000 reward for information leading to his arrest.

According to Superintendent Alex Marrero, East High School, where the incident occurred, is closed for the rest of the week. Counselors have been made available for those in need of support.

In the wake of the shooting, questions of gun control and stricter laws have been revisited in the Denver community while police continue their search for Lyle. Anybody with information is asked to come forward, and the police are optimistic they will quickly apprehend the perpetrator of this crime.

‘Mexico is not a US colony!’: AMLO Condemns Invasion Threats, Celebrates Nationalization of Oil, Lithium

All Global Research articles can be read in 51 languages by activating the Translate This Article button below the author’s name.

To receive Global Research’s Daily Newsletter (selected articles), click here.

Follow us on Instagram and Twitter and subscribe …

The post ‘Mexico is not a US colony!’: AMLO Condemns Invasion Threats, Celebrates Nationalization of Oil, Lithium appeared first on Global Research.